|
Volumn 313, Issue 14, 2015, Pages 1413-1414
|
Regenerative medicine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOMATERIAL;
BIOMIMETIC MATERIAL;
CHIMERIC ANTIGEN RECEPTOR;
DNA;
AGE RELATED MACULAR DEGENERATION;
BIOCOMPATIBILITY;
BONE MARROW TRANSPLANTATION;
CELL DIFFERENTIATION;
CELL THERAPY;
DNA MODIFICATION;
EMBRYONIC STEM CELL;
GRAFT VERSUS HOST REACTION;
HEART INFARCTION;
HEMATOLOGIC DISEASE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
IMMUNOPATHOLOGY;
MACULAR DEGENERATION;
MALIGNANT NEOPLASTIC DISEASE;
MEDICAL RESEARCH;
MESENCHYMAL STEM CELL TRANSPLANTATION;
NONHUMAN;
NOTE;
NUCLEAR REPROGRAMMING;
PLURIPOTENT STEM CELL;
PRIORITY JOURNAL;
REGENERATIVE MEDICINE;
STEM CELL TRANSPLANTATION;
T LYMPHOCYTE;
TISSUE ENGINEERING;
BIOLOGICAL THERAPY;
FORECASTING;
PROCEDURES;
TRENDS;
CELL- AND TISSUE-BASED THERAPY;
FORECASTING;
HUMANS;
REGENERATIVE MEDICINE;
TISSUE ENGINEERING;
|
EID: 84927946726
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2015.1492 Document Type: Note |
Times cited : (17)
|
References (8)
|